HIGHLIGHTS
- who: Barbara Vuic and collaborators from the Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka Cesta, , Zagreb, Croatia have published the research work: Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential, in the Journal: Biomedicines 2022, 10, 3000. of /2022/
- what: Significant progress in cannabinoid research, as well as the detection of CB2R expression in the brain, have directed investigation focus toward CR2R, as potential targets for treatment of neurodegenerative proteinopathies.
- future: Despite many promising findings in animal models further studies particularly clinical studies are needed before supporting the therapeutic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.